Alcohol Intake and Total Mortality in 142,960 Individuals from the MORGAM Project: a population-based study
AIM: To test the association of alcohol consumption with total and cause-specific mortality risk
DESIGN: Prospective observational multicentre population-based study
SETTING: Sixteen cohorts (15 from Europe) in the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) Project
PARTICIPANTS: A total of 142,960 individuals (mean age 50+/-13 y, 53.9% men) MEASUREMENTS: Average alcohol intake by food frequency questionnaire. Total and cause-specific mortality
FINDINGS: In comparison with lifetime abstainers, consumption of alcohol less than 10 gr/d was associated with an average 11% (95%CI: 7%-14%) reduction in the risk of total mortality, while intake >20 gr/d was associated with a 13% (7%-20%) increase in the risk of total mortality. Comparable findings were observed for cardiovascular (CV) deaths. As far as cancer is concerned, drinking up to 10 gr/d was not associated with either mortality risk reduction or increase, while alcohol intake >20 gr/d was associated with a 22% (10%-35%) increased risk of mortality. The association of alcohol with fatal outcomes was similar in men and women, differed somewhat between Countries and was more apparent in individuals preferring wine, suggesting that benefits may not be due to ethanol but other ingredients. Mediation analysis showed that HDLc explained 2.9% and 18.7% of the association between low alcohol intake and total as well as CV mortality, respectively.
CONCLUSIONS: In comparison with lifetime abstainers, consuming less than 1 drink per day (nadir at 5 gr/d) was associated with a reduced risk of total, cardiovascular and other causes mortality, except cancer. Intake of more than 2 drinks per day was associated with an increased risk of total, cardiovascular and especially cancer mortality.
Additional Info
-
Authors
Di Castelnuovo A.; Costanzo S.; Bonaccio M.; McElduff P.; Linneberg A.; Salomaa V.; Mannisto S.; Moitry M.; Ferrieres J.; Dallongeville J.; Thorand B.; Brenner H.; Ferrario M.; Veronesi G.; Pettenuzzo E.; Tamosiunas A.; Njolstad I.; Drygas W.; Nikitin Y.; Soderberg S.; Kee F.; Grassi G.; Westermann D.; Schrage B.; Dabboura S.; Zeller T.; Kuulasmaa K.; Blankenberg S.; Donati M. B.; de Gaetano G.; Iacoviello L.; Morgam Study Investigators -
Issue
Addiction . 2021 Jun 9. doi: 10.1111/add.15593. Online ahead of print. -
Published Date
9 june 2021
Related items
- Exploring the Associations Between Mediterranean Diet Adherence and Autoinflammation-Associated Skin Diseases
- Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups
- The illusion of healthy drinking: Methodological bias and selective reporting of effects shape evidence on alcohol and cardiovascular health
- A review of the relationship between dimensions of alcohol consumption and the burden of disease: 2026 update including Mendelian randomisation studies
- Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial